This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: University College Cardiff Consultants Limited. Active years: 2015-2017.
Location History:
- Cardiff, GB (2015 - 2016)
- South Glamorgan, GB (2017)
Company Filing History:
Years Active: 2015-2017
Title: Inventor Keith Gordon Harding: Innovating Wound Healing Solutions
Introduction: Keith Gordon Harding, based in Cardiff, GB, is an accomplished inventor known for his significant contributions in the field of wound healing. With a total of three patents to his name, Harding is dedicated to developing innovative solutions for chronic wounds, leveraging molecular targets to enhance healing processes.
Latest Patents: Among his notable patents, two stand out due to their groundbreaking approaches to wound management. The first, titled "Molecular Targets for Healing or Treating Wounds," focuses on a specific molecular target, PTPRK, which plays a crucial role in the healing of chronic human wounds. This patent outlines novel therapeutics and methods for effectively treating such wounds. The second, "Method and Kit for the Classification and Prognosis of Chronic Wounds," provides an innovative solution for identifying and determining the prognosis of chronic wound tissue in mammals. This method is based on a key set of molecular markers, offering insight into the type of wound and its healing trajectory.
Career Highlights: Keith Harding's tenure with University College Cardiff Consultants Limited has allowed him to apply his expertise in innovative research and development. His work has not only advanced the understanding of wound healing but also paved the way for practical applications that can improve patient outcomes.
Collaborations: Throughout his career, Harding has collaborated with esteemed colleagues, including Wenguo Jiang and Wen Guo Jiang. These partnerships have facilitated the exchange of ideas and expertise, fostering a collaborative environment that enhances research efficacy in the field of wound healing.
Conclusion: Keith Gordon Harding's commitment to innovation in wound care is evident through his groundbreaking patents and collaborative efforts. His research not only contributes to the scientific community but also holds the potential to transform the lives of individuals suffering from chronic wounds. As advancements continue, Harding's work remains a testament to the impact of innovative thinking in addressing significant medical challenges.